LAUSR

OBJECTIVE Anemia is common after cardiac surgery and, according to some suggestive evidence, may be associated with increased bleeding, other morbidity, and mortality. However, transfusion of red blood cells (RBC) may cause adverse effects and increase cost. The authors hypothesized that the restrictive hemoglobin threshold (Hb of 80 g/L) may aggravate bleeding more than the higher Hb threshold (Hb 100 g/L). DESIGN Prospective randomized trial. TYPE OF HOSPITAL University Hospital of Helsinki, Finland. PARTICIPANTS Eighty patients with written informed consent, scheduled for elective open-heart surgery were randomized in 2 groups. INTERVENTIONS Two study groups had RBC transfusion threshold of either Hb 80 g/L or 100 g/L. These triggers were followed for a 24-hour period postoperatively. A medical follow-up was carried out for 7 days after surgery. MEASUREMENTS AND MAIN RESULTS Rotational thromboelastometry (ROTEM) and conventional laboratory tests were performed to evaluate coagulation. There was no significant difference in bleeding or ROTEM parameters between the groups. Complication rate and Hb concentration after 7-day follow-up were not different between the groups, but Group 100 g/L had received twice the amount of RBC transfusions. CONCLUSION Hb threshold of 80 g/L for RBC transfusion in cardiac surgery is comparable to 100 g/L in terms of bleeding and possibly short-term complications.